Bacterial Histidine Kinase and the Development of Its Inhibitors in the 21st Century

Antibiotics (Basel). 2024 Jun 22;13(7):576. doi: 10.3390/antibiotics13070576.

Abstract

Bacterial histidine kinase (BHK) is a constituent of the two-component signaling (TCS) pathway, which is responsible for the regulation of a number of processes connected to bacterial pathogenicity, virulence, biofilm development, antibiotic resistance, and bacterial persistence. As BHK regulation is diverse, inhibitors can be developed, such as antibiotic synergists, bacteriostatic/bactericidal agents, virulence inhibitors, and biofilm inhibitors. Inhibition of essential BHK has always been an amenable strategy due to the conserved binding sites of the domains across bacterial species and growth dependence. Hence, an inhibitor of BHK might block multiple TCS regulatory networks. This review describes the TCS system and the role of BHK in bacterial virulence and discusses the available inhibitors of BHK, which is a specific response regulator with essential structural features.

Keywords: antibacterial resistance; bacterial histidine kinase; bacterial histidine kinase inhibitors; two-component signaling system.

Publication types

  • Review

Grants and funding

This research received no external funding.